Fall-Winter 2003-4 Newsletter - View PDF
Summer 2002 Newsletter - View PDF
Fall 2002 Newsletter - View PDF
Spring 2002 Newsletter - View PDF
Winter 2001-2 Newsletter - View PDF
Fall 2001 Newsletter - View PDF
Important Medical Notice - BAYCOL -
On August 8, 2001, Bayer voluntarily withdrew Baycol, (cerivastatin) from the U.S. market because of reports of sometimes fatal rhabdomyolysis, a severe adverse muscle reaction from this cholesterol-lowering product. The Food and Drug Administration (FDA) agreed with and supported Bayer's decision.
view full story »
